Galderma stock pre-market at EUR 171.28: minus 0.39 percent
Published on 10/07/2026 at 08:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Galderma stock was at EUR 171.28 pre-market at 8:25 a.m. CEST on October 7, 2026, down 0.39 percent versus the EUR 171.95 prior close at Lang & Schwarz on October 6, 2026.
Pre-market trading
The Lang & Schwarz quote showed a bid of EUR 170.40 and an ask of EUR 172.15. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Galderma stock.
Previous session
The prior close at Lang & Schwarz was EUR 171.95 on October 6, 2026. Galderma is listed on the SIX Swiss Exchange under the ticker GALD, according to the company’s published materials.
Restylane marks 30 years
In a release dated October 6, 2026, Galderma said it was marking 30 years since Restylane was launched in Europe as the first hyaluronic acid injectable. The company said the portfolio has administered 77 million treatments worldwide and highlighted recent approvals for Restylane Shaype in the European Union, a new Restylane syringe in the European Union, the United States and Canada, and Restylane Volyme in the United States.
Swiss Market Index inclusion
In a September 21, 2026 announcement distributed by Business Wire, Galderma said it began trading as a constituent of the Swiss Market Index. The company also reported first-half 2026 net sales growth of 24.6 percent at constant currency.
